Heart Failure Blood Tests: BNP and the Rest of the Panel

Heart Failure Blood Tests: BNP and the Rest of the Panel

Breathlessness when lying flat, chest pain, or fainting needs emergency care. Call 911 or go to the emergency department.

What does a blood panel for heart failure actually measure?

A heart failure panel measures three things at once: the stretch on the heart muscle, the condition of the organs that depend on good circulation, and the other problems that can worsen or imitate the same symptoms. No single number on the page carries a diagnosis by itself.

Heart failure is a clinical syndrome rather than a laboratory finding, identified from symptoms, physical signs and objective signs of impaired cardiac function 1. That matters for how you read your report. Breathlessness, ankle swelling, fatigue and reduced exercise tolerance belong to many conditions, so bloodwork exists to narrow the field rather than to settle it.

The first job of the panel is the natriuretic peptide, a hormone the heart itself releases when its walls are under pressure. The second job is organ surveillance: kidney markers, electrolytes, liver markers and a full blood count show how the rest of the body is coping and whether anything limits the options a clinician can consider. The third job is to look for contributors, including low iron, thyroid imbalance and raised blood glucose, each of which can make the same symptoms worse.

Research suggests that, in heart failure, blood biomarkers add diagnostic and prognostic information on top of history, examination and imaging rather than replacing any of them 2. In practice that means your results are read next to an ECG, an echocardiogram and what a clinician finds at the bedside.

This article is educational and is not medical advice.

Why do clinicians start with a natriuretic peptide test?

Clinicians start there because the heart produces these hormones in direct response to wall stretch, which makes them the closest thing in the blood to a readout of cardiac workload. B-type natriuretic peptide (BNP) and the N-terminal fragment of its precursor (NT-proBNP) come from the same molecule, and a laboratory measures one or the other, not usually both.

When pressure rises inside the heart chambers, muscle cells release the precursor hormone, which splits into the active peptide and the inactive fragment. The active form encourages the kidneys to pass more salt and water and relaxes blood vessels, which is the body's own attempt to reduce the load. Studies indicate that these peptides are central to identifying and ruling out heart failure in people presenting with breathlessness 3, and that their concentrations reflect the degree of cardiac wall stress and filling pressure 4.

The two forms behave differently in the tube and in the body. The inactive fragment stays in circulation longer and is cleared largely through the kidneys, so kidney function shifts its interpretation more. Assays also differ between manufacturers, which is why the number means most when it is compared with the range and cut point your own laboratory prints, and why serial results are best drawn at the same laboratory. If you want the mechanism and the reporting conventions in more detail, the dedicated guide on what is a bnp blood test covers them.

One practical point: a natriuretic peptide result is a triage and tracking tool, not a verdict. It tells a clinician how hard to look, and in which direction.

What can a raised natriuretic peptide result reflect?

A result above the cut point printed on your lab report says the heart muscle has been under more stretch than expected, and that a cardiac cause of your symptoms deserves a proper look. It does not name a condition on its own.

The chain is worth understanding. Observation: the number is high. Possible meaning: pressure inside the heart chambers has been elevated, which happens when the heart struggles to fill or to empty, when a valve leaks or narrows, or when the chambers are enlarged. Next step: a clinician compares the value with your symptoms, examination and imaging, and decides whether an echocardiogram or further assessment is warranted.

Several things other than heart failure can lift the same marker. Increasing age, reduced kidney function, atrial fibrillation and other heart rhythm problems, anaemia, severe infection, and conditions that strain the right side of the heart through the lungs can all raise it. Some medicines can also influence the result; ask your prescriber about anything you take before reading too much into one value.

Body size works in the other direction. A value outside the range on your report is worth discussing with a clinician promptly, and a value that is only modestly raised is still worth raising at your next appointment rather than filing away.

Can a normal result make heart failure unlikely?

Yes, in most non-acute situations a natriuretic peptide below the laboratory's cut point makes heart failure a much less likely explanation for breathlessness, which is exactly why the test is used early. Studies indicate that the main strength of these peptides lies in their ability to exclude the diagnosis when the result is low 3.

That strength has limits. A low value in someone with a high body mass index, or in someone whose symptoms have been treated and settled, is less reassuring than the same value in a lean, untreated person with new symptoms. Short, intermittent symptoms sampled on a good day can also produce a low reading. And a normal peptide does not exclude the other things on your list, from lung disease to low iron to deconditioning, all of which cause breathlessness with a quiet heart.

So the honest framing is this. A low result lowers the probability of heart failure substantially and usually redirects the search. It never cancels a persistent symptom. If breathlessness, swelling or fatigue continue after a reassuring result, that is a reason to go back to a clinician rather than to stop asking.

Why is the electrolyte balance watched closely?

Sodium is the electrolyte that tracks the relationship between salt and water in the blood, and it appears on a heart panel because that relationship shifts when circulation and the kidneys' handling of fluid change. A reading below the range printed on your lab report usually says more about water balance than about how much salt is on your food.

Sodium has its own biomarker guide covering what it measures, how it is tested, its ranges and how to read a result, so this page sticks to its role here. On a cardiac panel it is read beside potassium, kidney markers and body weight trends, and the direction of travel across repeat draws matters more than any single figure.

How should you read the ranges printed on your report?

Read the laboratory's own range first, because that is the range your sample was actually measured against. Reference ranges vary by laboratory, by assay, and by age and sex, which is why two reports with different numbers can both be interpreted correctly.

Marker Range on your lab report FitScript's optimal range
Sodium As printed on your lab report 138 to 142 mEq/L
Creatinine As printed on your lab report Read against the range your laboratory prints, then discuss with a clinician
Natriuretic peptide (BNP or NT-proBNP) As printed on your lab report Reported against the laboratory's own cut point, which differs by assay
Potassium As printed on your lab report Read against the range your laboratory prints, then discuss with a clinician

Optimal ranges are FitScript's optimization targets, not diagnostic cut-offs, and a value inside or outside them is not a diagnosis. Reference ranges vary by lab, age and sex, so compare like with like and keep your results from one laboratory where you can.

Creatinine deserves a note. It is a waste product of muscle turnover, so a muscular person can sit higher than a slight person with identical kidney function, and a person with very little muscle can sit deceptively low. That is why the estimated filtration rate calculated alongside it, and the trend across draws, carry more weight than one figure.

What do the kidney tests on the panel show?

Kidney markers show how well the organ that controls fluid volume is being supplied and how well it is clearing waste, which is inseparable from how the heart is performing. Creatinine, the estimated glomerular filtration rate derived from it, and urea or BUN form the core group, usually with potassium and the other electrolytes.

The physiology is a loop. The kidneys sense blood flow and pressure, and when they sense less, they hold on to salt and water and raise vascular tone. That increases the volume the heart has to move, which raises pressure inside the chambers, which in turn lifts the natriuretic peptide. Falling kidney function also slows clearance of that peptide, so the same degree of cardiac strain can produce a higher number in someone whose filtration rate is reduced.

Initial laboratory assessment in suspected heart failure conventionally includes a full blood count, serum electrolytes, urea and creatinine, glucose, liver markers and thyroid function 5. Those results also shape what a clinician can safely consider next, because kidney function and potassium influence many of the decisions that follow. Treatment decisions belong to a licensed provider, and some medicines shift these numbers on their own; ask your prescriber before interpreting a change.

Why are iron tests part of a heart panel?

Iron tests are included because low iron produces fatigue and breathlessness that overlap almost exactly with cardiac symptoms, and because iron is required for oxygen transport and for energy production inside muscle, including heart muscle. The usual group is ferritin, transferrin saturation and the full blood count, sometimes with serum iron and transferrin.

Research suggests that iron deficiency, with or without anaemia, is frequent in people with heart failure and that ferritin together with transferrin saturation forms the basis of its laboratory identification 6. Interpretation here has a trap worth knowing. Ferritin is also an acute phase protein, so inflammation lifts it even when stores are low, which is why transferrin saturation is read alongside it rather than ferritin being taken at face value.

The practical meaning for a reader is simple. If your haemoglobin is low or your iron markers sit outside the range on your report, that finding is worth discussing with a clinician promptly, because it changes both how your symptoms are explained and what a provider considers next. Do not start anything on your own: a licensed provider evaluates whether any intervention is appropriate, and the route and form matter.

What does thyroid testing have to do with the heart?

Thyroid hormone sets the metabolic pace of most tissues, including heart muscle and blood vessels, so a thyroid that is running fast or slow changes heart rate, the force of contraction and the resistance the heart pumps against. TSH, usually with free T4, is part of the conventional initial laboratory assessment in suspected heart failure 5.

An overactive thyroid tends to drive a faster resting pulse, palpitations and reduced exercise tolerance, and it can provoke or worsen atrial fibrillation. An underactive thyroid tends in the other direction, with fatigue, fluid retention, a slower pulse and shifts in blood lipids. Both patterns can muddy a cardiac assessment, and both are identifiable on a routine blood draw.

This is one of the more useful markers on a heart panel precisely because the finding changes the plan. If thyroid function sits outside the range on your report, the question becomes whether addressing it changes the cardiac picture. That is a conversation with a clinician, and any treatment decision belongs to a licensed provider.

Why would A1c or blood glucose be checked?

A1c is checked because glucose handling and cardiac workload travel together, and because the marker gives a three month average rather than a single morning snapshot. It measures the proportion of haemoglobin that has become glycated, so it reflects average exposure across the lifespan of red blood cells. Glucose is part of the conventional initial laboratory assessment in suspected heart failure 5.

Two caveats make A1c easier to read correctly. Anything that shortens red cell survival, including blood loss and certain inherited haemoglobin variants, can pull the result lower than true average glucose. Anything that lengthens it can push the result higher. In someone whose iron markers are also abnormal, A1c and iron results are best read as a pair rather than in isolation.

If your A1c sits above the range printed on your lab report, that is a finding to take to a clinician rather than a label to apply to yourself. The useful next step is a conversation about the whole metabolic picture, including fasting glucose, weight trend, blood pressure and lipids.

What else commonly appears on the panel?

Beyond the peptide, kidney, electrolyte, iron, thyroid and glucose markers, most panels add a full blood count, liver markers, albumin and often a general inflammation marker reported in words such as CRP, plus a urine test.

Each has a job. The full blood count detects anaemia and gives clues about infection. Liver markers can shift when the liver is congested by backed up venous pressure, so they act as a downstream signal of circulation rather than a liver problem in isolation. Albumin reflects both nutritional state and inflammation, and it is read alongside other markers of muscle and nutrition because body composition changes shape the course of chronic cardiac conditions. A biomarker signature covering inflammation, nutrition and muscle metabolism has been described in the assessment of sarcopenia and frailty in people with heart failure 7.

Inflammation markers are non specific by design. A raised value says something is provoking an inflammatory response somewhere, not what that something is, so it is interpreted in context and never alone. Research suggests that the clinical value of heart failure biomarkers lies in combining them with clinical assessment to refine diagnosis, grade severity and follow progress 8.

How is the test done, and what can change the result?

It is a standard venous blood draw, usually from the arm, with the natriuretic peptide collected into a specific tube because the peptide is sensitive to how the sample is handled. Most people are in and out in a few minutes, and results come back through the ordering clinician or the laboratory portal.

Fasting depends on what else is on the requisition. The peptide itself is not the reason a laboratory asks you to fast; lipids or fasting glucose on the same form may be. Follow the instructions your laboratory or clinician gives you, and tell the phlebotomist if you did not follow them, because that context changes how the result is read.

Several things move the numbers independently of your heart. Hydration status affects electrolytes and creatinine. Hard exercise in the preceding day or two can raise creatinine through muscle turnover. Posture and tourniquet time can nudge potassium. Age and kidney function both shift peptide concentrations. Some medicines change several markers at once; ask your prescriber rather than adjusting anything yourself, because any change belongs to the clinician who issued it.

Assay differences matter more than most people expect. Because manufacturers calibrate differently, a value from one laboratory is not directly comparable with a value from another, and a change between two laboratories may be a change in method rather than in you.

What does repeat testing over time add?

Repeat testing turns a single snapshot into a direction, and direction is usually the more useful piece of information. A peptide that falls as symptoms settle, and a kidney function that holds steady, tell a different story from the same numbers measured once.

Serial measurement is one of the recognised uses of these markers in ongoing care alongside diagnosis and risk assessment 2, and research suggests that their day to day value lies in guiding assessment and follow up rather than in standing alone as a test result 8. Where a clinician is tracking a chronic condition, the question is rarely whether a number is above a line. It is whether the number is moving, in which direction, and whether the symptoms agree.

That is also the logic behind broad, repeated panels generally. FitScript members have 150+ biomarkers tested per year, and Atlas, FitScript's AI health advisor, reads each result against the member's own previous values rather than against a one off threshold. Any decision about care that follows is made by a licensed provider after reviewing the person.

For anyone tracking a known cardiac condition, how results are interpreted also depends on where things stand clinically, which is what the staging language used by clinicians describes.

When is a result worth discussing with a clinician?

Any value outside the range printed on your lab report is worth discussing with a clinician, and a natriuretic peptide above the laboratory's cut point is worth raising promptly rather than at some future appointment. The same applies to a falling filtration rate, a potassium or sodium outside the printed range, a low haemoglobin, or iron markers that sit low.

Symptoms carry at least as much weight as numbers. New or worsening breathlessness, needing more pillows at night, swelling in the ankles or abdomen, a rapid rise in weight over a few days, waking short of breath, or a sharp drop in what you can do without stopping are all reasons to contact a clinician, whatever the last blood test showed.

Breathlessness when lying flat, chest pain, or fainting is different. Those signs need emergency care: call 911 or go to the emergency department. Do not wait for a repeat blood test to explain them.

Discuss your results and any treatment with a clinician or licensed provider, who can weigh your bloodwork against your examination, your imaging and your history. A laboratory report describes a moment in your physiology. A clinician decides what it means for you.

Key takeaways

Related reading: the guide to heart failure stages explains how clinicians describe progression and why the same blood result is weighted differently at different points.

References

  1. Heart failure--definition and diagnosis. Indian Heart Journal, 2005.
  2. Biomarkers for the diagnosis and management of heart failure. Heart Failure Reviews, 2022.
  3. Biomarkers in heart failure: a focus on natriuretic peptides. Heart (British Cardiac Society), 2024.
  4. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides. Heart Failure Clinics, 2018.
  5. Diagnosis and evaluation of heart failure. American Family Physician, 2012.
  6. Heart Failure-Related Iron Deficiency Anemia Pathophysiology and Laboratory Diagnosis. Current Heart Failure Reports, 2023.
  7. Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?. Current Heart Failure Reports, 2022.
  8. Biomarkers in heart failure: Relevance in the clinical practice. International Journal of Cardiology, 2022.

Common questions

Is there one blood test that confirms congestive heart failure?

No. A natriuretic peptide test (BNP or NT-proBNP) is the central blood marker, but it is read alongside kidney, electrolyte, iron, thyroid and blood sugar results, plus an ECG and an echocardiogram. A clinician makes the diagnosis from the whole picture, not from one number.

What does BNP actually measure?

BNP stands for B-type natriuretic peptide, a hormone released by heart muscle when the chamber walls are stretched by pressure or volume. The result reflects how hard the heart has been working, not a named condition. Your laboratory prints its own cut point, because assays differ between labs.

Do I need to fast before a heart failure blood test?

That depends on what else is on the request form, not on the peptide itself. Panels that include fasting glucose or lipids often ask for a fasting sample. Follow the instructions your laboratory or clinician gives you, and tell the phlebotomist if you were unable to follow them.

Can a normal BNP or NT-proBNP rule heart failure out?

A result below the laboratory's cut point makes heart failure a much less likely explanation for breathlessness, which is why the test is used early. It is less reassuring in people with a high body mass index or in someone whose symptoms have already settled. Persistent symptoms still deserve review by a clinician.

Why are kidney tests ordered at the same time?

The heart and kidneys share one circulation, so reduced blood flow changes how the kidneys handle salt and water, and reduced kidney function changes how the peptide is cleared from the blood. Creatinine, the estimated filtration rate and electrolytes also shape what options a clinician can safely consider next.

What do iron tests add to the panel?

Ferritin and transferrin saturation show both iron stores and how much iron is available to tissues, and low iron causes fatigue and breathlessness that look a lot like cardiac symptoms. Ferritin also rises with inflammation, so the two markers are read together. A clinician decides what any low result means for you.

How often should these tests be repeated?

There is no single schedule. The interval depends on your symptoms, how stable things are and what a clinician is tracking, and it is set by the person managing your care. Where possible, use the same laboratory each time, because results from different assays are not directly comparable.

What should I do if a result sits outside the range on my report?

Contact the clinician who ordered the test and discuss it promptly rather than waiting for a routine review. Bring the full report, not one line of it, along with any symptom changes and your recent weight trend. If you are breathless lying flat, have chest pain, or faint, call 911 or go to the emergency department.

Related reading